ES8603178A1 - Procedimiento para preparar pirrolo-bencimidazoles - Google Patents

Procedimiento para preparar pirrolo-bencimidazoles

Info

Publication number
ES8603178A1
ES8603178A1 ES542976A ES542976A ES8603178A1 ES 8603178 A1 ES8603178 A1 ES 8603178A1 ES 542976 A ES542976 A ES 542976A ES 542976 A ES542976 A ES 542976A ES 8603178 A1 ES8603178 A1 ES 8603178A1
Authority
ES
Spain
Prior art keywords
preparation
alkenyl
benzimidazoles
pyrrolo
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542976A
Other languages
English (en)
Other versions
ES542976A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843417643 external-priority patent/DE3417643A1/de
Priority claimed from DE19843446417 external-priority patent/DE3446417A1/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES8603178A1 publication Critical patent/ES8603178A1/es
Publication of ES542976A0 publication Critical patent/ES542976A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE PIRROLOBENCIMIDAZOLES, DE SUS TAUTOMEROS Y SALES DE ADICION DE ACIDOS FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE T REPRESENTA OXIGENO O AZUFRE; PY REPRESENTA UN RADICAL 2-. 3- O 4-PIRIDILO Y R1 Y R2 PUEDEN SER VARIOS TIPOS DE RADICALES. COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA PY-X-CO-Y, EN LAS QUE Y REPRESENTA HIDROGENO O RADICAL FACILMENTE SEPARABLE, Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I); SEGUIDA DE LA CICLIZACION DEL COMPUESTO FORMADO EN MEDIO ACIDO. TAMBIEN SE PUEDEN EMPLEAR OTROS COMPUESTOS DE PARTIDA PARA EFECTUAR LA REACCION. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA MEJORAR LA FUERZA DEL CORAZON Y LA MICROCIRCULACION Y POR SU EFECTO HIPOTENSOR.
ES542976A 1984-05-12 1985-05-09 Procedimiento para preparar pirrolo-bencimidazoles Granted ES542976A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843417643 DE3417643A1 (de) 1984-05-12 1984-05-12 Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE19843446417 DE3446417A1 (de) 1984-12-20 1984-12-20 Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte

Publications (2)

Publication Number Publication Date
ES8603178A1 true ES8603178A1 (es) 1986-01-01
ES542976A0 ES542976A0 (es) 1986-01-01

Family

ID=25821132

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542976A Granted ES542976A0 (es) 1984-05-12 1985-05-09 Procedimiento para preparar pirrolo-bencimidazoles

Country Status (18)

Country Link
US (2) US4666923A (es)
EP (1) EP0161632B1 (es)
JP (2) JPH0647593B2 (es)
KR (1) KR870001201B1 (es)
AU (1) AU560349B2 (es)
DE (1) DE3582447D1 (es)
DK (1) DK209585A (es)
ES (1) ES542976A0 (es)
FI (1) FI81351C (es)
GR (1) GR851085B (es)
HU (1) HU193754B (es)
IL (1) IL75120A (es)
NO (1) NO851862L (es)
NZ (1) NZ212005A (es)
PH (1) PH22863A (es)
PL (2) PL147842B1 (es)
PT (1) PT80425B (es)
SU (1) SU1480770A3 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR851085B (es) * 1984-05-12 1985-11-25 Boehringer Mannheim Gmbh
DE3445669A1 (de) * 1984-12-14 1986-06-19 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3524067A1 (de) * 1985-07-05 1987-01-08 Boehringer Mannheim Gmbh Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3530825A1 (de) * 1985-08-29 1987-03-05 Boehringer Mannheim Gmbh Neue benzodipyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3626664A1 (de) * 1986-08-07 1988-02-11 Boehringer Mannheim Gmbh Tricyclische benzotriazole, verfahren zu ihrer herstellung sowie arzneimittel
DE3639466A1 (de) * 1986-11-18 1988-05-19 Thomae Gmbh Dr K Neue pyrrolo-benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3642315A1 (de) * 1986-12-11 1988-06-23 Boehringer Mannheim Gmbh Neue pyrrolobenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
DE3740985A1 (de) * 1987-12-03 1989-06-15 Boehringer Mannheim Gmbh Verwendung linear anellierter tricyclen als hemmer der erythrozytenaggregation
DE3855327D1 (de) * 1987-12-30 1996-07-04 Orion Yhtymae Oy Heterocyclische Verbindungen
US4963677A (en) * 1987-12-30 1990-10-16 Orion Corporation Ltd. Heterocyclic lactam compounds
DE3803775A1 (de) * 1988-02-09 1989-08-17 Boehringer Mannheim Gmbh Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US5324911A (en) * 1990-01-08 1994-06-28 Schroer Manufacturing Company Heated animal surgery table
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20060142247A1 (en) * 2004-12-17 2006-06-29 Guy Georges Tricyclic heterocycles
KR20070113286A (ko) * 2005-04-14 2007-11-28 에프. 호프만-라 로슈 아게 아미노피라졸 유도체, 이의 제조 및 약학 제제로서의 용도
DE602006002887D1 (de) * 2005-04-14 2008-11-06 Hoffmann La Roche Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel
BRPI0619955A2 (pt) * 2005-12-15 2011-10-25 Hoffmann La Roche derivados tricìclicos da lactama, sua produção e seus usos como agentes farmacêuticos
JP2009530337A (ja) * 2006-03-23 2009-08-27 エフ．ホフマン−ラ ロシュ アーゲー 置換インダゾール誘導体、その製造方法、及びその薬剤としての利用法
US8063225B2 (en) 2006-08-14 2011-11-22 Chembridge Corporation Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
RU2443704C1 (ru) * 2010-10-29 2012-02-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СУЛЬФАТЫ 2-АРИЛ-4-ДИАЛКИЛАМИНОЭТИЛ-3-ФЕНИЛПИРРОЛО[1,2-a]-БЕНЗИМИДАЗОЛОВ, ОБЛАДАЮЩИЕ АНТИОКСИДАНТНЫМИ И АНТИРАДИКАЛЬНЫМИ СВОЙСТВАМИ
DK2681236T3 (en) 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
KR101706877B1 (ko) 2012-09-13 2017-02-15 에프. 호프만-라 로슈 아게 Cns 장애의 치료를 위한 2-옥소-2,3-다이하이드로-인돌
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
GB201709456D0 (en) * 2017-06-14 2017-07-26 Ucb Biopharma Sprl Therapeutic agents
EP4706758A3 (en) 2019-05-21 2026-05-06 Ardelyx, Inc. Methods for inhibiting phosphate transport
JP6854953B1 (ja) 2020-06-16 2021-04-07 株式会社ソディック ワイヤ放電加工装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1158532A (en) * 1967-01-05 1969-07-16 Centre Nat Rech Scient 2-Oxoindoline-3-Carboxylic Acids and Esters thereof
BE714717A (es) * 1967-05-12 1968-09-30
FR1529901A (fr) * 1967-05-12 1968-06-21 Centre Nat Rech Scient Procédé de préparation de lactames se rattachant à l'indolinone et à l'oxo quinoléine
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
GR851085B (es) * 1984-05-12 1985-11-25 Boehringer Mannheim Gmbh

Also Published As

Publication number Publication date
AU560349B2 (en) 1987-04-02
HU193754B (en) 1987-11-30
DE3582447D1 (de) 1991-05-16
FI81351C (fi) 1990-10-10
DK209585D0 (da) 1985-05-10
EP0161632A3 (en) 1986-06-11
EP0161632A2 (de) 1985-11-21
PT80425B (de) 1987-04-16
JPH0772185B2 (ja) 1995-08-02
KR870001201B1 (ko) 1987-06-20
JPH0741474A (ja) 1995-02-10
PT80425A (de) 1985-06-01
JPH0647593B2 (ja) 1994-06-22
AU4222285A (en) 1985-11-14
KR850008170A (ko) 1985-12-13
SU1480770A3 (ru) 1989-05-15
DK209585A (da) 1985-11-13
US4963686A (en) 1990-10-16
PH22863A (en) 1989-01-19
EP0161632B1 (de) 1991-04-10
FI81351B (fi) 1990-06-29
GR851085B (es) 1985-11-25
NO851862L (no) 1985-11-13
HUT37938A (en) 1986-03-28
US4666923A (en) 1987-05-19
IL75120A (en) 1989-02-28
IL75120A0 (en) 1985-09-29
PL144822B1 (en) 1988-07-30
JPS60246386A (ja) 1985-12-06
FI851869L (fi) 1985-11-13
PL253246A1 (en) 1986-08-26
ES542976A0 (es) 1986-01-01
FI851869A0 (fi) 1985-05-10
NZ212005A (en) 1989-07-27
PL147842B1 (en) 1989-08-31

Similar Documents

Publication Publication Date Title
ES8603178A1 (es) Procedimiento para preparar pirrolo-bencimidazoles
ES8603455A1 (es) Un metodo para preparar derivados de piperazina
NZ208831A (en) Imidazolium derivatives and pharmaceutical compositions
ES8705371A1 (es) Procedimiento para preparar derivados de amino-propanol
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
HUT49149A (en) Process for production of derivatives of amin acid and medical compositions containing them as active substance
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
IL62894A (en) Dibenzoxazepine derivatives,process for preparing the same and pharmaceutical compositions comprising the same
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
ES8701189A1 (es) Procedimiento para preparar derivados s(carbamoil-fenilsele-nicos) de mercaptanos
GR862247B (en) Novel pyrrolo-benzimidazole pyrrolo-benzoxazole and pyrrolo-benzthiazole process for their preparation and medicaments containing said compounds
ES8506626A1 (es) Derivados de la 1, 4-dihidropiridina
IL74800A (en) Esters of 4-aryl-1,4,5,7-tetrahydro-5-oxothieno(3,4-b)-pyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL61261A (en) Pyridine and pyrimidine derivatives and pharmaceutical compositions containing them
HUT50485A (en) Process for production of derivatives of amin acid and medical compositions containing them as active substance
EP0173377A3 (en) Pyrimidone compounds, their preparation and pharmaceutical compositions containing them
EP0207483A3 (en) Benzimidazoles, process for their preparation, medicaments containing them and intermediates
HUT47918A (en) Process for production of heterocyclic compositions and medical compositions containing them as active substance
JPS5756425A (en) Hypotensor
DE3650347D1 (de) 1,4-Benzodioxanderivate, Verfahren zu deren Herstellung, pharmakologische Zusammensetzung und deren Verwendung.
NO164170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater.
GB1263404A (en) Bornanecarboxamide derivatives and a process for the preparation thereof
ES8303346A1 (es) "un procedimiento de preparacion de derivados de piridina".
ES8104265A1 (es) Un procedimiento para la preparacion de nuevas bencenosulfi-namidas

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960401